SK Biopharmaceuticals third-quarter profit rises 66%

Reported by 1 outlet · first reported Nov 4, 9:05 AM ET

SK Biopharmaceuticals reported operating profit up 66% in the third quarter. Strong U.S. sales of its seizure drug drove the gain.

Sources

This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.